Clinical Trial Update: Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC [Phase 2]

View source ↗

Summary

Phase 2 pilot/feasibility study evaluating reduced-intensity hematopoietic stem cell transplant for MonoMAC syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gata2 Deficiency
• Immunodeficiency
• Myelodysplastic Syndromes

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: MDS, Immunodeficiency | Phase 2 | Status: COMPLETED | Results posted: 2017-11-30